Seminars in Cell and Developmental Biology

SEMINARS IN CELL AND DEVELOPMENTAL BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 1084-9521 DESCRIPTION . Seminars in Cell and Developmental Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular cell and developmental biology. Each issue is thematic, devoted to an important topic of interest to cell and developmental biologists, focusing on the latest advances and their specific implications. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains authoritative invited reviews on different aspects of the subject area. We aim to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. IMPACT FACTOR . 2020: 7.727 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline EMBiology Elsevier BIOBASE Biological Abstracts Biological & Agricultural Index BIOSIS Previews Current Awareness in Biological Sciences Current Contents Genetics Abstracts Science Citation Index Embase Chemical Abstracts Biosciences EDITORIAL BOARD . Editor-in-Chief John Davey, University of Warwick, Coventry, United Kingdom AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/semcdb 1 Editorial Advisory Board Matthew Freeman, Sir William Dunn School of Pathology, Oxford, United Kingdom Richard Harvey, Victor Chang Cardiac Research Institute, Darlinghurst, Australia Shigeo Hayashi, RIKEN Center for Developmental Biology, Kobe, Japan Edith Heard, National Institute of Health and Medical Research, Paris, France Jonathan Millar, University of Warwick, Coventry, United Kingdom Guangshuo Ou, Tsinghua University, Beijing, China Catherine Rabouille, Hubrecht Institute, Utrecht, Netherlands Melina Schuh, Max Planck Institute for Biophysical Chemistry Department of Meiosis, Göttingen, Germany Robert Schulz†, University of Notre Dame, Notre Dame, Indiana, United States of America Matt Sweet, The University of Queensland Institute for Molecular Bioscience, Brisbane, Australia Keiko Torii, University of Washington, Seattle, Washington, United States of America Gisou Van der Goot, Federal Polytechnic School of Lausanne, Lausanne, Switzerland K. VijayRaghavan, Tata Institute of Fundamental Research Library, Bangalore, India James Whisstock, Monash University Department of Biochemistry and Molecular Biology, Clayton, Australia Magdalena Zernicka-Goetz, University of Cambridge, Cambridge, United Kingdom AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/semcdb 2 GUIDE FOR AUTHORS . INTRODUCTION Seminars in Cell and Developmental Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular cell and developmental biology, on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cell and developmental biologists, focusing on the latest advances and their specific implications. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. Types of paper Please note that Seminars in Cell and Developmental Biology is a commissioned review journal and does not accept unsolicited articles. Contact details for submission For questions on the submission and reviewing process, or if you are interested in acting as a Guest Editor, please contact the Editorial Office at [email protected]. If you have been invited to submit, please submit your article via https://www.editorialmanager.com/YSCDB/default.aspx. Please do not submit unsolicited articles to this page, and do not use the page to submit pre-submission inquiries. For pre-submission inquiries, contact the Editorial Office instead. For technical queries, please use our help site at: https://service.elsevier.com/. Here you will be able to learn more about our online submission and editorial system via interactive tutorials, explore a range of problem solutions via our knowledgebase, and find answers to frequently asked questions. You will also find our 24/7 support contact details should you need any assistance from one of our customer service representatives. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements AUTHOR INFORMATION PACK 26 Sep 2021 www.elsevier.com/locate/semcdb 3 For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information. Submission declaration and verification Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright- holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check. Preprints Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information). Use of inclusive language Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Changes to authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following

Load more